Development of AC265347‐Inspired Calcium‐Sensing Receptor Ago‐Positive Allosteric Modulators
- 2 July 2021
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 16 (22) , 3451-3462
Abstract
The calcium‐sensing receptor (CaSR) is a clinical target in the treatment of hyperparathyroidism and related diseases. However, clinical use of approved CaSR‐targeting drugs such as cinacalcet is limited due to adverse side effects including hypocalcaemia, nausea and vomiting, and in some instances, a lack of efficacy. The CaSR agonist and positive allosteric modulator (ago‐PAM), AC265347, is chemically distinct from clinically‐approved CaSR PAMs. AC265347 potently suppressed parathyroid hormone (PTH) release in rats with a lower propensity to cause hypocalcaemia compared to cinacalcet and may therefore offer benefits over current CaSR PAMs. Here we report a structure activity relationship (SAR) study seeking to optimise AC265347 as a drug candidate and disclose the discovery of AC265347‐like compounds with diverse pharmacology and improved physicochemical and drug‐like properties.Keywords
Funding Information
- Australian Research Council (DP170104228)
- Australian Research Council (FT160100075, FT170100392)
This publication has 28 references indexed in Scilit:
- Cinacalcet use and the risk of cardiovascular events, fractures and mortality in chronic kidney disease patients with secondary hyperparathyroidismScientific Reports, 2018
- Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate ReceptorsChemical Reviews, 2016
- Clinical and Practical Use of Calcimimetics in Dialysis Patients With Secondary HyperparathyroidismClinical Journal of the American Society of Nephrology, 2016
- Towards tissue-specific pharmacology: insights from the calcium-sensing receptor as a paradigm for GPCR (patho)physiological biasTrends in Pharmacological Sciences, 2015
- Calcium-sensing receptor 20 years laterAmerican Journal of Physiology-Cell Physiology, 2014
- Role of the calcium-sensing receptor in extracellular calcium homeostasisBest Practice & Research Clinical Endocrinology & Metabolism, 2013
- A Monod-Wyman-Changeux Mechanism Can Explain G Protein-coupled Receptor (GPCR) Allosteric ModulationJournal of Biological Chemistry, 2012
- Characterization of Highly Efficacious Allosteric Agonists of the Human Calcium-Sensing ReceptorThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Discovery of a class of calcium sensing receptor positive allosteric modulators; 1-(benzothiazol-2-yl)-1-phenylethanolsBioorganic & Medicinal Chemistry Letters, 2010
- Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving HemodialysisNew England Journal of Medicine, 2004